C-CAMP launches 9th edition of national bio entrepreneurship competition with Rs 20 cr at stake
India’s largest biotech startup competition returns with Rs 20 crore prize pool, widening push to back science-led innovation beyond metro hubs.
The Centre for Cellular and Molecular Platforms has launched the ninth edition of the National Bio Entrepreneurship Competition (NBEC) 2026, stepping up its push to back early-stage life sciences ventures with one of the largest prize pools in India’s biotech startup ecosystem.
The competition, unveiled at C-CAMP’s Bengaluru campus, was attended by Priyank Kharge, Karnataka’s Minister for Electronics, IT/BT and Rural Development, alongside senior government officials and industry leaders including C-CAMP CEO and director Taslimarif Saiyed.
Now in its ninth year, NBEC has emerged as a key pipeline for science-led startups in India, drawing more than 21,000 applications since its inception in 2017 and backing over 130 winning ideas with cumulative prizes and investment opportunities exceeding Rs 40 crore.
This year’s edition raises the stakes further, offering up to Rs 20 crore in cash prizes and investment opportunities, positioning it among the country’s largest platforms for biotech entrepreneurship. Applications are open until May 31.
Speaking at the launch, Kharge said the competition reflects Karnataka’s ambition to remain at the forefront of biotechnology innovation. In a post on X, he noted that NBEC has helped “translate cutting-edge innovations into solutions that create real impact,” pointing to its growing national footprint beyond metro hubs.
Saiyed described the platform as a “powerful amplifier” of early-stage biotech ventures, adding that several past participants have gone on to achieve global recognition. “With a growing network of partners and increased funding support, this year’s edition aims to attract innovative ideas from across India,” he said.
Broadening the innovation funnel
NBEC 2026 will feature two parallel tracks—one for startups and independent innovators, and another dedicated to student teams. While student winners can receive up to Rs 10 lakh in prize money, the startup track will account for the bulk of the Rs 20 crore pool, including potential investment backing.
Shortlisted participants across both tracks will also gain access to mentorship from industry leaders and take part in an entrepreneurship development boot camp designed to refine business and commercialization skills.
The competition spans a wide set of focus areas, including healthcare, vaccines, medical devices, diagnostics, digital health, and artificial intelligence, alongside sectors such as agritech, environmental biotechnology, and clean energy.
C-CAMP said the platform has played a role in decentralizing innovation, with applications coming from 35 states and union territories, including a growing share from Tier II and Tier III cities—regions traditionally underrepresented in India’s startup ecosystem.
A strategic bet on biotech
The launch comes amid a broader policy push to strengthen India’s biotechnology and deep-tech sectors, where commercialization cycles are longer and funding gaps remain more pronounced compared with consumer internet startups.
Backed by multiple government agencies including the Department of Biotechnology and NITI Aayog, C-CAMP has incubated and supported more than 650 startups over the past decade, while maintaining a wider network of over 3,000 entrepreneurs.
As competition intensifies globally in areas such as genomics, therapeutics, and climate biotech, platforms like NBEC are increasingly being positioned not just as grant competitions, but as early-stage deal funnels connecting scientific talent with capital.
With a larger prize pool and expanded scope, NBEC 2026 appears aimed at scaling that rolebridging the gap between lab-stage innovation and venture-backed growth in India’s evolving biotech landscape.